173 related articles for article (PubMed ID: 18665173)
1. Changes in subcellular localisation of MI-ER1 alpha, a novel oestrogen receptor-alpha interacting protein, is associated with breast cancer progression.
McCarthy PL; Mercer FC; Savicky MW; Carter BA; Paterno GD; Gillespie LL
Br J Cancer; 2008 Aug; 99(4):639-46. PubMed ID: 18665173
[TBL] [Abstract][Full Text] [Related]
2. The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer.
Mintz PJ; Habib NA; Jones LJ; Giamas G; Lewis JS; Bowen RL; Coombes RC; Stebbing J
Cancer; 2008 Sep; 113(6):1489-95. PubMed ID: 18615623
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the zinc-finger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesis.
Riku M; Inaguma S; Ito H; Tsunoda T; Ikeda H; Kasai K
Oncotarget; 2016 Feb; 7(5):5690-701. PubMed ID: 26744317
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
[TBL] [Abstract][Full Text] [Related]
5. Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival.
Campo L; Turley H; Han C; Pezzella F; Gatter KC; Harris AL; Fox SB
J Pathol; 2005 Apr; 205(5):585-91. PubMed ID: 15776477
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.
Chen C; Zhou Z; Sheehan CE; Slodkowska E; Sheehan CB; Boguniewicz A; Ross JS
Int J Cancer; 2009 Jun; 124(12):2829-36. PubMed ID: 19267401
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast.
Baqai T; Shousha S
Histopathology; 2003 May; 42(5):440-7. PubMed ID: 12713620
[TBL] [Abstract][Full Text] [Related]
8. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
Steinman S; Wang J; Bourne P; Yang Q; Tang P
Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
[TBL] [Abstract][Full Text] [Related]
9. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
10. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
11. Low Expression of Estrogen Receptor-α and Progesterone Receptor in Human Breast Cancer Tissues Is Associated With High-Grade Human Cytomegalovirus Protein Expression.
Rahbar A; Touma J; Costa H; Davoudi B; Bukholm IR; Sauer T; Vetvik K; Geisler J; Söderberg-Naucler C
Clin Breast Cancer; 2017 Nov; 17(7):526-535.e1. PubMed ID: 28595965
[TBL] [Abstract][Full Text] [Related]
12. Expression of nuclear insulin receptor substrate 1 in breast cancer.
Sisci D; Morelli C; Garofalo C; Romeo F; Morabito L; Casaburi F; Middea E; Cascio S; Brunelli E; Andò S; Surmacz E
J Clin Pathol; 2007 Jun; 60(6):633-41. PubMed ID: 16882697
[TBL] [Abstract][Full Text] [Related]
13. p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2.
Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
Breast Cancer Res; 2004; 6(5):R571-85. PubMed ID: 15318938
[TBL] [Abstract][Full Text] [Related]
14. [E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast].
Han A; Xiong M; Li Z; Liang Y
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):27-30. PubMed ID: 11866953
[TBL] [Abstract][Full Text] [Related]
15. Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma.
Logullo AF; Stiepcich MM; Osório CA; Nonogaki S; Pasini FS; Rocha RM; Soares FA; Brentani MM
Histopathology; 2011 Mar; 58(4):617-25. PubMed ID: 21371080
[TBL] [Abstract][Full Text] [Related]
16. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
17. Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation.
Oka K; Suzuki T; Onodera Y; Miki Y; Takagi K; Nagasaki S; Akahira J; Ishida T; Watanabe M; Hirakawa H; Ohuchi N; Sasano H
Int J Cancer; 2011 Apr; 128(8):1770-82. PubMed ID: 20533549
[TBL] [Abstract][Full Text] [Related]
18. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
19. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM
Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943
[TBL] [Abstract][Full Text] [Related]
20. Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma.
Sreekumar S; Levine KM; Sikora MJ; Chen J; Tasdemir N; Carter D; Dabbs DJ; Meier C; Basudan A; Boone D; McAuliffe PF; Jankowitz RC; Lee AV; Atkinson JM; Oesterreich S
Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32609836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
